Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02409043 · ClinicalTrials.gov registry record
Neuronal and Glial Biomarkers in Stroke
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 99
- Enrollment target
NCT02409043 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 99 participants.
The verdict
NCT02409043 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if there are molecules in the blood that indicate when a person has had a stroke, and what type of stroke they have had, so that appropriate treatment may be begun as soon as possible. This study is also being conducted to determine whether these molecules can help to predict long-term health following stroke. Some of these potential molecules, also called biomarkers, include Neuronal biomarker ubiquitin C-terminal hydrolase-L1 (UCH-L1), Glial markers such as glial fibrillary acidic protein (GFAP), and a neuroprotective enzyme called angiotensin converting enzyme 2 (ACE2), which has activity that has been shown to be helpful cardiovascular disease and shown to be altered in animal models of acute stroke, where it is also shown to provide neuronal protection.
Interventions
- OTHER Blood draw
- OTHER Stroke blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02409043
The ClinicalTrials.gov registry entry for NCT02409043 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT02409043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02409043 about?
NCT02409043 is a clinical study titled "Neuronal and Glial Biomarkers in Stroke". The purpose of this research study is to determine if there are molecules in the blood that indicate when a person has had a stroke, and what type of stroke they have had, so that appropriate treatment may be begun as soon as possible. This study is also being conducted to determine whether these mo...
What is the current status of trial NCT02409043?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2014-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02409043?
The interventions under investigation include: Blood draw (OTHER), Stroke blood draw (OTHER).
Who is sponsoring clinical trial NCT02409043?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.